FDA approves sublingual buprenorphine-naloxone combo for opioid dependence July 8, 2013Addiction MedicinePain
U.S. Cymbalta cost highest in international comparisonApril 25, 2013DepressionPainBusiness of Medicine
Neurotic excoriation case treated successfully with onabotulinumtoxinAFebruary 14, 2013Addiction MedicinePain
Panel votes against hydrocodone because of abuse potentialDecember 10, 2012PainNeurologyAddiction Medicine